To date, there is no randomized, controlled evidence that tocilizumab is an effective treatment for CRS.
Hadi sasa, hakuna ushahidi wenye utaratibu maalum, uliodhibitiwa wa kuwa tocimizumab ni matatibabu bora ya CRS.